These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 10499503)

  • 21. Anorectic effects of estrogen may be mediated by decreased neuropeptide-Y release in the hypothalamic paraventricular nucleus.
    Bonavera JJ; Dube MG; Kalra PS; Kalra SP
    Endocrinology; 1994 Jun; 134(6):2367-70. PubMed ID: 8194462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AMP-activated protein kinase activates neuropeptide Y neurons in the hypothalamic arcuate nucleus to increase food intake in rats.
    Kohno D; Sone H; Tanaka S; Kurita H; Gantulga D; Yada T
    Neurosci Lett; 2011 Jul; 499(3):194-8. PubMed ID: 21658429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropeptide Y in central control of feeding and interactions with orexin and leptin.
    Niimi M; Sato M; Taminato T
    Endocrine; 2001 Mar; 14(2):269-73. PubMed ID: 11394646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The feeding response to melanin-concentrating hormone is attenuated by antagonism of the NPY Y(1)-receptor in the rat.
    Chaffer CL; Morris MJ
    Endocrinology; 2002 Jan; 143(1):191-7. PubMed ID: 11751609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of central neuropeptide Y Y1 receptors potently stimulates food intake in male rhesus monkeys.
    Larsen PJ; Tang-Christensen M; Stidsen CE; Madsen K; Smith MS; Cameron JL
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3781-91. PubMed ID: 10523030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple NPY receptors Inhibit GABA(A) synaptic responses of rat medial parvocellular effector neurons in the hypothalamic paraventricular nucleus.
    Pronchuk N; Beck-Sickinger AG; Colmers WF
    Endocrinology; 2002 Feb; 143(2):535-43. PubMed ID: 11796508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The hypothalamic paraventricular nucleus is not essential for orexigenic NPY or anorexigenic melanocortin action.
    Dube MG; Kalra SP; Kalra PS
    Peptides; 2006 Sep; 27(9):2239-48. PubMed ID: 16759748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NPY presynaptic actions are reduced in the hypothalamic mpPVN of obese (fa/fa), but not lean, Zucker rats in vitro.
    Pronchuk N; Colmers WF
    Br J Pharmacol; 2004 Mar; 141(6):1032-6. PubMed ID: 14967739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin and insulin-like growth factor II suppress neuropeptide Y release from the nerve terminals in the paraventricular nucleus: a putative hypothalamic site for energy homeostasis.
    Sahu A; Dube MG; Phelps CP; Sninsky CA; Kalra PS; Kalra SP
    Endocrinology; 1995 Dec; 136(12):5718-24. PubMed ID: 7588328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Central stimulation of oxytocin release in the lactating rat: interaction of neuropeptide Y with alpha-1-adrenergic mechanisms.
    Parker SL; Crowley WR
    Endocrinology; 1993 Feb; 132(2):658-66. PubMed ID: 8381069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased receptor sensitivity to neuropeptide Y in the hypothalamus may underlie transient hyperphagia and body weight gain.
    Kalra PS; Dube MG; Xu B; Kalra SP
    Regul Pept; 1997 Oct; 72(2-3):121-30. PubMed ID: 9652971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feeding inhibition by urocortin in the rat hypothalamic paraventricular nucleus.
    Wang C; Mullet MA; Glass MJ; Billington CJ; Levine AS; Kotz CM
    Am J Physiol Regul Integr Comp Physiol; 2001 Feb; 280(2):R473-80. PubMed ID: 11208577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastric acid secretion induced by paraventricular nucleus microinjection of orexin A is mediated through activation of neuropeptide Yergic system.
    Kermani M; Eliassi A
    Neuroscience; 2012 Dec; 226():81-8. PubMed ID: 22986171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex differences in the sympathoexcitatory response to insulin in obese rats: role of neuropeptide Y.
    Shi Z; Cassaglia PA; Pelletier NE; Brooks VL
    J Physiol; 2019 Mar; 597(6):1757-1775. PubMed ID: 30628058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypothalamic paraventricular 5-hydroxytryptamine: receptor-specific inhibition of NPY-stimulated eating and energy metabolism.
    Currie PJ; Coiro CD; Niyomchai T; Lira A; Farahmand F
    Pharmacol Biochem Behav; 2002 Apr; 71(4):709-16. PubMed ID: 11888562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice.
    Kanatani A; Mashiko S; Murai N; Sugimoto N; Ito J; Fukuroda T; Fukami T; Morin N; MacNeil DJ; Van der Ploeg LH; Saga Y; Nishimura S; Ihara M
    Endocrinology; 2000 Mar; 141(3):1011-6. PubMed ID: 10698177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic intracerebroventricular administration of anti-neuropeptide Y antibody stimulates starvation-induced feeding via compensatory responses in the hypothalamus.
    Ishii T; Muranaka R; Tashiro O; Nishimura M
    Brain Res; 2007 May; 1144():91-100. PubMed ID: 17320051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropeptide Y loses its orexigenic effect in rats with lesions of the hypothalamic paraventricular nucleus.
    Wang J; Yuan Z; Dong J; Zhang D; Usami T; Murata T; Narita K; Higuchi T
    Endocr Res; 2013; 38(1):8-14. PubMed ID: 22594946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orexigenic effect of the melanocortin MC4 receptor antagonist HS014 is inhibited only partially by neuropeptide Y Y1 receptor selective antagonists.
    Kask A; Schiöth HB; Harro J; Wikberg JE; Rägo L
    Can J Physiol Pharmacol; 2000 Feb; 78(2):143-9. PubMed ID: 10737677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Receptor subtypes Y1 and Y5 mediate neuropeptide Y induced feeding in the guinea-pig.
    Lecklin A; Lundell I; Paananen L; Wikberg JE; Männistö PT; Larhammar D
    Br J Pharmacol; 2002 Apr; 135(8):2029-37. PubMed ID: 11959807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.